Risks of Severe COVID-19 Outcomes Among Patients With Diabetic Polyneuropathy in the United States.

ABSTRACT:

Context

Diabetic neuropathy (DN) affects more than 50% of diabetic patients who are also likely to have compromised immune system and respiratory function, both of which can make them susceptible to the SARS-CoV-2 virus.

Objective

To assess the risk of severe COVID-19 illness among adults with DN, compared with those with no DN and those with no diabetes.

Setting

The analysis utilized electronic health records from 55 US health care organizations in the TriNetX research database.

Design

A retrospective cohort study.

Participants

The analysis included 882 650 adults diagnosed with COVID-19 in January 2020 to June 2021, including 16 641 with DN, 81 329 with diabetes with no neuropathy, and 784 680 with no diabetes.

Outcome measures

The presence of h

SUBMITTER: Tuan WJ 

PROVIDER: S-EPMC9528940 | biostudies-literature | 2022 Nov-Dec 01

REPOSITORIES: biostudies-literature